The Meso-telencephalic Dopamine Consortium (DopaNet)

Project Number NW110

Chairs


Professor Jean-Pierre Changeux - Institut Pasteur, Paris, France
Dr. Nicolas Le Novère, EMBL-EBI, Cambridge, UK

Top of page

Abstract


The aim of this Network is to mobilise the European scientific expertise in molecular and cellular neurobiology, in order to investigate precisely and quantitatively all the aspects of neurotransmission – at the levels of the molecule, the supra-molecular assembly, the neuronal cell and neuronal network – in a specific neuronal system that is involved in many neurological disorders such as Parkinson’s disease, schizophrenia and drug abuse. The resulting integrated knowledge will not only provide relevant, up-to-date information, methods and tools for the diagnosis and treatment of such disorders, but also form a firm substrate to link the function of the neurobiological structures and the implementation of cognitive and mental abilities.

Download the DopaNet flyer  

Visit the DopaNet Web Site

Top of page 

Duration


3 years, from 1 January 2003 to 31 December 2005.

Top of page